Evercore ISI maintains Arch Capital stock rating on buyback boost By Investing.com

Arch Capital expanded its share repurchase authorization by $3 billion, leaving about $3.1 billion remaining, which Evercore ISI views as an offset to slower growth and weaker underwriting income. The firm expects just 1.3% net premiums written growth in 2026 and forecasts share repurchases of $2.75 billion in 2026 and $2.58 billion in 2027, above consensus. However, Evercore’s EPS estimates remain 3% below consensus and it sees pricing pressure worsening loss ratios in reinsurance.

Analysis

The signal here is less about Arch Capital’s near-term earnings and more about the maturity of its capital base. When a reinsurer starts returning incremental capital faster than it can deploy it into accretive underwriting, the equity behaves more like a shrinking net-asset vehicle than a growth compounder; that tends to support valuation in the short run but caps multiple expansion over 6-12 months. The buyback also mechanically offsets some of the EPS drag from softer underwriting, which is why the market may initially reward the headline even if the business mix is deteriorating underneath.

The second-order effect is on relative quality within property/casualty. If pricing pressure is broadening, firms with better access to excess capital will be able to defend reported EPS via repurchases, while smaller peers without similar flexibility will show the pain more directly in book value and combined ratio trends. That creates a dispersion trade: the market may keep paying for “capital return certainty” even as underwriting alpha compresses across the cycle, which tends to favor balance-sheet strength over pure top-line growth in the next few quarters.

The contrarian view is that aggressive repurchases can be value-destructive if underwriting margins are inflecting lower at the same time. Buying back stock at ~8x earnings is not obviously cheap if the E is peaking and the franchise is transitioning into slower growth; in that case the buyback is a timing tool, not a strategy edge. The key catalyst to watch over the next 1-2 quarters is whether loss trends stabilize enough to preserve book value growth; if not, the market may start treating the authorization as a symptom of capital misallocation rather than shareholder friendliness.

Key Decisions for Investors

• Maintain a tactical long in ACGL for 1-3 months only if the market keeps rewarding the buyback headline; target a 5-8% upside move, but cut exposure if book value growth or underwriting metrics roll over in the next earnings print.
• Use ACGL strength to express a relative-value short against a higher-quality P&C carrier with stronger underwriting momentum; the thesis is that capital returns can mask decelerating franchise economics for 1-2 quarters, but not indefinitely.
• Buy ACGL put spreads 3-6 months out if the stock re-rates above the current multiple without an underwriting inflection; this is a cleaner way to fade the buyback-driven support with defined risk.
• For event-driven investors, pair long ACGL with short a weaker reinsurer lacking buyback capacity; the spread should work if the cycle turns more pricing-competitive and capital return becomes the main differentiator.
• Do not chase TERN or HHH off the ancillary headlines; these look like low-conviction adjacent names unless there is a clearer operating catalyst, and any bid there is likely to be short-lived.